Orchestra BioMed (OBIO) Institutional Ownership $5.77 +0.33 (+6.07%) (As of 11/22/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Orchestra BioMed (NASDAQ:OBIO)CurrentInstitutional OwnershipPercentage53.55%Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$14.75MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$452.98K Get OBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Orchestra BioMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OBIO Institutional Buying and Selling by Quarter Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Orchestra BioMed Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/21/2024 SkyView Investment Advisors LLC12,284$63K0.0%-38.6%0.032% 11/19/2024 Barclays PLC31,785$163K0.0%+281.3%0.084% 11/16/2024 Geode Capital Management LLC567,219$2.92M0.0%+2.0%1.492% 11/15/2024 Barclays PLC31,785$163K0.0%+281.3%0.084% 11/15/2024 Jane Street Group LLC19,070$98K0.0%-19.8%0.050% 11/15/2024 State Street Corp429,613$2.21M0.0%+12.4%1.130% Get the Latest News and Ratings for OBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Orchestra BioMed and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 RTW Investments LP8,206,159$42.18M0.6%+46.0%21.587% 11/13/2024 The Manufacturers Life Insurance Company 33,305$171K0.0%-20.9%0.088% 11/12/2024 Charles Schwab Investment Management Inc.217,008$1.12M0.0%+3.9%0.574% 11/1/2024 ABLE Financial Group LLC13,402$69K0.0%N/A0.035% 10/3/2024 SG Americas Securities LLC10,143$52K0.0%N/A0.028% 8/16/2024 SkyView Investment Advisors LLC20,000$163K0.0%N/A0.056% 8/15/2024 The Manufacturers Life Insurance Company42,082$343K0.0%+8.4%0.118% 8/1/2024 Rhumbline Advisers26,439$215K0.0%+192.7%0.074% 7/26/2024 Bank of New York Mellon Corp70,682$576K0.0%+115.7%0.197% 5/15/2024 Price T Rowe Associates Inc. MD571,075$3.01M0.0%-8.3%1.596% 5/11/2024 Catalytic Wealth RIA LLC22,261$117K0.0%N/A0.062% 2/1/2024 New York State Common Retirement Fund3,623$33K0.0%-68.6%0.010% 10/27/2023 Allspring Global Investments Holdings LLC4,904$43K0.0%N/A0.014% 10/27/2023 TD Asset Management Inc92,678$808K0.0%+100.0%0.259% 10/24/2023 Bank of New York Mellon Corp40,290$351K0.0%+211.2%0.113% 10/18/2023 UMB Bank n.a.3,160$28K0.0%N/A0.009% 10/13/2023 Arkadios Wealth Advisors51,595$450K0.0%N/A0.144% 8/24/2023 Perceptive Advisors LLC2,052,868$14.37M0.4%-9.9%5.744% 8/11/2023 Atika Capital Management LLC64,651$453K0.0%N/A0.181% 5/16/2023 Boxer Capital LLC250,000$4.89M0.2%N/A2.230% 5/15/2023 RTW Investments LP5,118,507$100.17M2.1%N/A45.652% 4/18/2023IFP Advisors Inc2,980$34K0.0%N/A0.027% (Data available from 1/1/2016 forward) OBIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OBIO shares? During the previous two years, 23 institutional investors and hedge funds held shares of Orchestra BioMed. The most heavily invested institutionals were RTW Investments LP ($42.18M), Perceptive Advisors LLC ($14.37M), Boxer Capital LLC ($4.89M), Price T Rowe Associates Inc. MD ($3.01M), Geode Capital Management LLC ($2.92M), State Street Corp ($2.21M), and Charles Schwab Investment Management Inc. ($1.12M).Learn more on OBIO's institutional investors. What percentage of Orchestra BioMed stock is owned by institutional investors? 53.55% of Orchestra BioMed stock is owned by institutional investors. Learn more on OBIO's institutional investor holdings. Which institutional investors have been buying Orchestra BioMed stock? Of the 19 institutional investors that purchased Orchestra BioMed stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RTW Investments LP ($7.70M), Boxer Capital LLC ($250K), Bank of New York Mellon Corp ($65.25K), Atika Capital Management LLC ($64.65K), Arkadios Wealth Advisors ($51.60K), State Street Corp ($47.31K), and Barclays PLC ($46.90K). How much institutional buying is happening at Orchestra BioMed? Institutional investors have bought a total of 8,392,674 shares in the last 24 months. This purchase volume represents approximately $121.49M in transactions. Which Orchestra BioMed major shareholders have been selling company stock? The following institutional investors have sold Orchestra BioMed stock in the last 24 months: Perceptive Advisors LLC ($225.36K), Price T Rowe Associates Inc. MD ($51.53K), The Manufacturers Life Insurance Company ($8.78K), New York State Common Retirement Fund ($7.93K), SkyView Investment Advisors LLC ($7.72K), and Jane Street Group LLC ($4.71K). How much institutional selling is happening at Orchestra BioMed? Institutional investors have sold a total of 306,027 shares in the last 24 months. This volume of shares sold represents approximately $2.03M in transactions. Related Companies EMBC Institutional Ownership OFIX Institutional Ownership IRMD Institutional Ownership KIDS Institutional Ownership SRDX Institutional Ownership SIBN Institutional Ownership TMCI Institutional Ownership TCMD Institutional Ownership CVRX Institutional Ownership RCEL Institutional Ownership This page (NASDAQ:OBIO) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchestra BioMed Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orchestra BioMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
